These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 20544536
1. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation. Rybakowska I, Bakuła S, Klimek J, Milczarek R, Smolenski RT, Kaletha K. Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):453-6. PubMed ID: 20544536 [Abstract] [Full Text] [Related]
2. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart. Kalsi KK, Yuen AH, Johnson PH, Birks EJ, Yacoub MH, Smolenski RT. Nucleosides Nucleotides Nucleic Acids; 2005 Jun; 24(4):287-8. PubMed ID: 16021918 [Abstract] [Full Text] [Related]
6. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E. Int J Cardiol; 2005 May 25; 101(2):191-5. PubMed ID: 15882662 [Abstract] [Full Text] [Related]
7. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly? Pérez M, Martin MA, Cañete S, Rubio JC, Fernández-Moreira D, San Juan AF, Gómez-Gallego F, Santiago C, Arenas J, Lucia A. Int J Sports Med; 2006 Jun 25; 27(6):429-35. PubMed ID: 16767606 [Abstract] [Full Text] [Related]
9. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C. Am Heart J; 2006 Oct 25; 152(4):736-41. PubMed ID: 16996850 [Abstract] [Full Text] [Related]
10. Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease. Agewall S, Norman B. Pathophysiol Haemost Thromb; 2006 Oct 25; 35(6):440-4. PubMed ID: 17565237 [Abstract] [Full Text] [Related]
11. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL. J Card Fail; 2005 Dec 25; 11(9):677-83. PubMed ID: 16360962 [Abstract] [Full Text] [Related]
12. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA. Am Heart J; 2006 Aug 25; 152(2):312-20. PubMed ID: 16875916 [Abstract] [Full Text] [Related]
13. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR. Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700 [Abstract] [Full Text] [Related]